Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

10 May 2016 - 16 May 2016
11 May 2016 - 13 May 2016

Partners to Develop Methodologies for Ensuring Quality of Stem Cell Production

By BiotechDaily International staff writers
Posted on 12 Nov 2012
Print article
Biotech companies from the United States and Europe have recently announced an agreement to cooperate on the development of methodologies to enable the consistent production of large quantities of stem cells for research and clinical use.

The American company EMD Millipore (Billerica, MA, USA) offers a broad range of innovative products, services, and business relationships in research, development, and production of biotech and pharmaceutical drug therapies. EMD Millipore is the life science division of Merck KGaA, (Darmstadt, Germany).

The other partner to the agreement is Sistemic Ltd. (Glasgow, United Kingdom). Sistemic is a leading provider of microRNA-based problem-solving services and kit-based products. Their extensive suite of tools for the cell therapy community includes SistemQCT, which is used to characterize cells including stem cells with regard to cell identity, purity, potency, and safety as well as monitoring production quality control. In addition, the drug development market is served through a range of products which include SistemTOXT, SistemKBT, and SistemRNAT.

Under terms of the newly announced agreement the companies will jointly develop proprietary monitoring methodology utilizing Sistemic's microRNA marker detection capability to enable consistent growth of stem cells in EMD Millipore's Mobius CellReady platform. Markers developed in the course of this project may also be incorporated into commercially available kits for quality control of stem cells cultures.

"To advance the progress of stem cell products toward clinical use, it is critical to ensure the consistency and quality of large-scale culture systems," said Robert Shaw, commercial director of EMD Millipore's Stem Cell Initiative. "We are excited to be partnering with Sistemic, as the company's leading microRNA-based solutions will help us continue our efforts toward the commercialization of stem cell processing."

"We are delighted to enter this collaborative arrangement with EMD Millipore," said Jim Reid, CEO of Sistemic. "The fact that EMD Millipore has chosen Sistemic as its collaborative partner is yet another validation of our ground-breaking research and ability to develop systems for quality control of stem cells, and other mutually beneficial products and programs."

Related Links:
EMD Millipore
Merck KGaA
Sistemic Ltd.


Print article

Channels

Genomics/Proteomics

view channel
Image: An artistic rendering of the Zika virus structure (Photo courtesy of Dr. Guntur Fibriansah, Duke-NUS Medical School).

High Resolution Structure of Zika virus Expected to Aid Vaccine Development

A team of molecular virologists used advanced cryo-electron microscopy techniques to establish a high-resolution structure for the Zika virus, a formerly neglected pathogen that has recently been associated... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.